Association of Non-LDL Indices with Recurrent Stroke Risk while on Lipid-Modifying Therapy

Aims: Low-density lipoprotein (LDL)-lowering statin therapy is an established secondary stroke prevention strategy. However, the differential impact of key non-LDL levels on recurrent stroke risk, while on lipid-modifying therapy (LT), remains unclear. Methods: We analyzed the dataset of a multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong-Ho, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049477/
https://www.ncbi.nlm.nih.gov/pubmed/31189759
http://dx.doi.org/10.5551/jat.49304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049477/
https://www.ncbi.nlm.nih.gov/pubmed/31189759
http://dx.doi.org/10.5551/jat.49304

Ejemplares similares